192 related articles for article (PubMed ID: 25129395)
1. A randomized, blinded, controlled USA field study to assess the use of fluralaner tablets in controlling canine flea infestations.
Meadows C; Guerino F; Sun F
Parasit Vectors; 2014 Aug; 7():375. PubMed ID: 25129395
[TBL] [Abstract][Full Text] [Related]
2. A randomized, blinded, controlled USA field study to assess the use of fluralaner topical solution in controlling canine flea infestations.
Meadows C; Guerino F; Sun F
Parasit Vectors; 2017 Jan; 10(1):36. PubMed ID: 28103945
[TBL] [Abstract][Full Text] [Related]
3. A randomized, blinded, controlled and multi-centered field study comparing the efficacy and safety of Bravecto (fluralaner) against Frontline (fipronil) in flea- and tick-infested dogs.
Rohdich N; Roepke RK; Zschiesche E
Parasit Vectors; 2014 Mar; 7():83. PubMed ID: 24593931
[TBL] [Abstract][Full Text] [Related]
4. A randomized, controlled field study to assess the efficacy and safety of lotilaner flavored chewable tablets (Credelio™) in eliminating fleas in client-owned dogs in the USA.
Karadzovska D; Chappell K; Coble S; Murphy M; Cavalleri D; Wiseman S; Drake J; Nanchen S
Parasit Vectors; 2017 Nov; 10(1):528. PubMed ID: 29089063
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of a novel oral isoxazoline, sarolaner (Simparica™) in the treatment of naturally occurring flea and tick infestations in dogs presented as veterinary patients in Europe.
Becskei C; De Bock F; Illambas J; Mahabir SP; Farkas R; Six RH
Vet Parasitol; 2016 May; 222():49-55. PubMed ID: 26994516
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of a novel oral chewable combination tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio™) against natural flea infestations in client-owned dogs in the USA.
Kryda K; Mahabir SP; Inskeep T; Rugg J
Parasit Vectors; 2020 Mar; 13(1):98. PubMed ID: 32113472
[TBL] [Abstract][Full Text] [Related]
7. A randomised, blinded, controlled field study to assess the efficacy and safety of lotilaner tablets (Credelio™) in controlling fleas in client-owned dogs in European countries.
Cavalleri D; Murphy M; Seewald W; Drake J; Nanchen S
Parasit Vectors; 2017 Nov; 10(1):526. PubMed ID: 29089065
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of sarolaner (Simparica™) against fleas on dogs presented as veterinary patients in the United States.
Cherni JA; Mahabir SP; Six RH
Vet Parasitol; 2016 May; 222():43-8. PubMed ID: 26947964
[TBL] [Abstract][Full Text] [Related]
9. A randomized, blinded, controlled USA field study to assess the use of fluralaner topical solution in controlling feline flea infestations.
Meadows C; Guerino F; Sun F
Parasit Vectors; 2017 Jan; 10(1):37. PubMed ID: 28103942
[TBL] [Abstract][Full Text] [Related]
10. Clinical field study of the safety and efficacy of spinosad chewable tablets for controlling fleas on dogs.
Robertson-Plouch C; Baker KA; Hozak RR; Zimmermann AG; Parks SC; Herr C; Hart LM; Jay J; Hutchens DE; Snyder DE
Vet Ther; 2008; 9(1):26-36. PubMed ID: 18415944
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of sarolaner (Simparica
Packianathan R; Colgan S; Hodge A; Davis K; Six RH; Maeder S
Parasit Vectors; 2017 Aug; 10(1):387. PubMed ID: 28814332
[TBL] [Abstract][Full Text] [Related]
12. Onset of activity of fluralaner (BRAVECTO™) against Ctenocephalides felis on dogs.
Taenzler J; Wengenmayer C; Williams H; Fourie J; Zschiesche E; Roepke RK; Heckeroth AR
Parasit Vectors; 2014 Dec; 7():567. PubMed ID: 25471474
[TBL] [Abstract][Full Text] [Related]
13. Field effectiveness and safety of fluralaner plus moxidectin (Bravecto® Plus) against ticks and fleas: a European randomized, blinded, multicenter field study in naturally-infested client-owned cats.
Rohdich N; Zschiesche E; Wolf O; Loehlein W; Pobel T; Gil MJ; Roepke RKA
Parasit Vectors; 2018 Nov; 11(1):598. PubMed ID: 30454052
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of fluralaner and afoxolaner treatments to control flea populations, reduce pruritus and minimize dermatologic lesions in naturally infested dogs in private residences in west central Florida USA.
Dryden MW; Canfield MS; Kalosy K; Smith A; Crevoiserat L; McGrady JC; Foley KM; Green K; Tebaldi C; Smith V; Bennett T; Heaney K; Math L; Royal C; Sun F
Parasit Vectors; 2016 Jun; 9(1):365. PubMed ID: 27352607
[TBL] [Abstract][Full Text] [Related]
15. A small-scale open-label study of the treatment of canine flea allergy dermatitis with fluralaner.
Fisara P; Shipstone M; von Berky A; von Berky J
Vet Dermatol; 2015 Dec; 26(6):417-20, e97-8. PubMed ID: 26271195
[TBL] [Abstract][Full Text] [Related]
16. A randomized, controlled field study to assess the efficacy and safety of lotilaner (Credelio™) in controlling fleas in client-owned cats in Europe.
Cavalleri D; Murphy M; Seewald W; Nanchen S
Parasit Vectors; 2018 Jul; 11(1):410. PubMed ID: 30001744
[TBL] [Abstract][Full Text] [Related]
17. Open field study on the efficacy of oral fluralaner for long-term control of flea allergy dermatitis in client-owned dogs in Ile-de-France region.
Crosaz O; Chapelle E; Cochet-Faivre N; Ka D; Hubinois C; Guillot J
Parasit Vectors; 2016 Mar; 9():174. PubMed ID: 27007494
[TBL] [Abstract][Full Text] [Related]
18. A randomized, controlled field study to assess the efficacy and safety of lotilaner flavored chewable tablets (Credelio™ CAT) in eliminating fleas in client-owned cats in the USA.
Chappell K; Paarlberg T; Seewald W; Karadzovska D; Nanchen S
Parasit Vectors; 2021 Mar; 14(1):127. PubMed ID: 33648556
[TBL] [Abstract][Full Text] [Related]
19. Dog owner flea/tick medication purchases in the USA.
Lavan R; Armstrong R; Tunceli K; Normile D
Parasit Vectors; 2018 Nov; 11(1):581. PubMed ID: 30400923
[TBL] [Abstract][Full Text] [Related]
20. A single topical fluralaner application to cats and to dogs controls fleas for 12 weeks in a simulated home environment.
Ranjan S; Young D; Sun F
Parasit Vectors; 2018 Jul; 11(1):385. PubMed ID: 29970135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
